A comparison of speech outcomes using radical intravelar veloplasty or Furlow palatoplasty for the treatment of velopharyngeal insufficiency associated with occult submucous cleft palate

Paul Nader Afrooz, Zoe Macisaac, Stephen Rottgers, Matthew Ford, Lorelei J. Grunwaldt, Anand R. Kumar

Research output: Contribution to journalArticle

Abstract

Background: The safety, efficacy, and direct comparison of various surgical treatments for velopharyngeal insufficiency (VPI) associated with occult submucous cleft palate (OSMCP) are poorly characterized. The aim of this study was to report and analyze the safety and efficacy of Furlow palatoplasty (FP) versus radical intravelar veloplasty (IVV) for treatment of VPI associated with OSMCP. Methods: A retrospective review of one institution's experience treating VPI associated with OSMCP using IVV (group 1) or FP (group 2) during 24 months was performed. Statistical significance was determined by Wilcoxon matched-pair, Independent-Samples Mann-Whitney U, and analysis of variance (SPSS 20.0.0). Results: In group 1 (IVV), 18 patients were identified from August 2010 to 2011 (12 male and 6 female patients; average age, 5.39 years). Seven patients were syndromic and 11 were nonsyndromic. In group 2 (FP), 17 patients were identified from August 2009 to 2011 (8 male and 9 female patients; average age, 8.37 years). Three patients were syndromic and 14 patients were nonsyndromic. There was statistical significance between the average pretreatment Pittsburgh Weighted Speech Score (PWSS) of the 2 groups (group 1 and 2 averages 19.06 and 11.05, respectively, P = 0.002), but there was no statistical significance postoperatively (group 1 and 2 averages 4.50 and 4.69, respectively, P = 0.405). One patient from each group required secondary speech surgery. Average operative time was greater for FP (140 minutes; range, 93-177 minutes) compared to IVV (95 minutes; range, 58-135 minutes), P <0.001. Average hospital stay was 3.9 days for IVV (range, 2-9 days) and 3.2 days for FP (range, 2-6 days), with no significant difference (P = 0.116). There were no postsurgical wound infections, oral-nasal fistulas, postoperative bleeding complications, or mortalities. Conclusions: Nonsyndromic patients with hypernasal speech are treated effectively and safely with either IVVor FP. Intravelar veloplasty trended toward lower speech scores than FP (76% IVV, 58% FP PWSS absolute reduction). Syndromic patients with OSMCP may be more effectively treated with FP (72% IVV vs 79% FP PWSS absolute reduction). Intravelar veloplasty is associated with shorter operative times. Both techniques are associated with low morbidity, improved speech scores, and low reoperative rates.

Original languageEnglish (US)
Pages (from-to)182-186
Number of pages5
JournalAnnals of Plastic Surgery
Volume74
Issue number2
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Velopharyngeal Insufficiency
Cleft Palate
Therapeutics
Operative Time
Oral Fistula
Safety
Wound Infection
Nose
Length of Stay
Analysis of Variance

Keywords

  • Cleft palate repair
  • Congenital
  • Intravelar veloplasty
  • Occult submucous cleft palate
  • Velopharyngeal incompetence

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

A comparison of speech outcomes using radical intravelar veloplasty or Furlow palatoplasty for the treatment of velopharyngeal insufficiency associated with occult submucous cleft palate. / Afrooz, Paul Nader; Macisaac, Zoe; Rottgers, Stephen; Ford, Matthew; Grunwaldt, Lorelei J.; Kumar, Anand R.

In: Annals of Plastic Surgery, Vol. 74, No. 2, 2015, p. 182-186.

Research output: Contribution to journalArticle

@article{1220c6fcdaea43eea4d40eae31af0457,
title = "A comparison of speech outcomes using radical intravelar veloplasty or Furlow palatoplasty for the treatment of velopharyngeal insufficiency associated with occult submucous cleft palate",
abstract = "Background: The safety, efficacy, and direct comparison of various surgical treatments for velopharyngeal insufficiency (VPI) associated with occult submucous cleft palate (OSMCP) are poorly characterized. The aim of this study was to report and analyze the safety and efficacy of Furlow palatoplasty (FP) versus radical intravelar veloplasty (IVV) for treatment of VPI associated with OSMCP. Methods: A retrospective review of one institution's experience treating VPI associated with OSMCP using IVV (group 1) or FP (group 2) during 24 months was performed. Statistical significance was determined by Wilcoxon matched-pair, Independent-Samples Mann-Whitney U, and analysis of variance (SPSS 20.0.0). Results: In group 1 (IVV), 18 patients were identified from August 2010 to 2011 (12 male and 6 female patients; average age, 5.39 years). Seven patients were syndromic and 11 were nonsyndromic. In group 2 (FP), 17 patients were identified from August 2009 to 2011 (8 male and 9 female patients; average age, 8.37 years). Three patients were syndromic and 14 patients were nonsyndromic. There was statistical significance between the average pretreatment Pittsburgh Weighted Speech Score (PWSS) of the 2 groups (group 1 and 2 averages 19.06 and 11.05, respectively, P = 0.002), but there was no statistical significance postoperatively (group 1 and 2 averages 4.50 and 4.69, respectively, P = 0.405). One patient from each group required secondary speech surgery. Average operative time was greater for FP (140 minutes; range, 93-177 minutes) compared to IVV (95 minutes; range, 58-135 minutes), P <0.001. Average hospital stay was 3.9 days for IVV (range, 2-9 days) and 3.2 days for FP (range, 2-6 days), with no significant difference (P = 0.116). There were no postsurgical wound infections, oral-nasal fistulas, postoperative bleeding complications, or mortalities. Conclusions: Nonsyndromic patients with hypernasal speech are treated effectively and safely with either IVVor FP. Intravelar veloplasty trended toward lower speech scores than FP (76{\%} IVV, 58{\%} FP PWSS absolute reduction). Syndromic patients with OSMCP may be more effectively treated with FP (72{\%} IVV vs 79{\%} FP PWSS absolute reduction). Intravelar veloplasty is associated with shorter operative times. Both techniques are associated with low morbidity, improved speech scores, and low reoperative rates.",
keywords = "Cleft palate repair, Congenital, Intravelar veloplasty, Occult submucous cleft palate, Velopharyngeal incompetence",
author = "Afrooz, {Paul Nader} and Zoe Macisaac and Stephen Rottgers and Matthew Ford and Grunwaldt, {Lorelei J.} and Kumar, {Anand R.}",
year = "2015",
doi = "10.1097/SAP.0b013e3182956632",
language = "English (US)",
volume = "74",
pages = "182--186",
journal = "Annals of Plastic Surgery",
issn = "0148-7043",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A comparison of speech outcomes using radical intravelar veloplasty or Furlow palatoplasty for the treatment of velopharyngeal insufficiency associated with occult submucous cleft palate

AU - Afrooz, Paul Nader

AU - Macisaac, Zoe

AU - Rottgers, Stephen

AU - Ford, Matthew

AU - Grunwaldt, Lorelei J.

AU - Kumar, Anand R.

PY - 2015

Y1 - 2015

N2 - Background: The safety, efficacy, and direct comparison of various surgical treatments for velopharyngeal insufficiency (VPI) associated with occult submucous cleft palate (OSMCP) are poorly characterized. The aim of this study was to report and analyze the safety and efficacy of Furlow palatoplasty (FP) versus radical intravelar veloplasty (IVV) for treatment of VPI associated with OSMCP. Methods: A retrospective review of one institution's experience treating VPI associated with OSMCP using IVV (group 1) or FP (group 2) during 24 months was performed. Statistical significance was determined by Wilcoxon matched-pair, Independent-Samples Mann-Whitney U, and analysis of variance (SPSS 20.0.0). Results: In group 1 (IVV), 18 patients were identified from August 2010 to 2011 (12 male and 6 female patients; average age, 5.39 years). Seven patients were syndromic and 11 were nonsyndromic. In group 2 (FP), 17 patients were identified from August 2009 to 2011 (8 male and 9 female patients; average age, 8.37 years). Three patients were syndromic and 14 patients were nonsyndromic. There was statistical significance between the average pretreatment Pittsburgh Weighted Speech Score (PWSS) of the 2 groups (group 1 and 2 averages 19.06 and 11.05, respectively, P = 0.002), but there was no statistical significance postoperatively (group 1 and 2 averages 4.50 and 4.69, respectively, P = 0.405). One patient from each group required secondary speech surgery. Average operative time was greater for FP (140 minutes; range, 93-177 minutes) compared to IVV (95 minutes; range, 58-135 minutes), P <0.001. Average hospital stay was 3.9 days for IVV (range, 2-9 days) and 3.2 days for FP (range, 2-6 days), with no significant difference (P = 0.116). There were no postsurgical wound infections, oral-nasal fistulas, postoperative bleeding complications, or mortalities. Conclusions: Nonsyndromic patients with hypernasal speech are treated effectively and safely with either IVVor FP. Intravelar veloplasty trended toward lower speech scores than FP (76% IVV, 58% FP PWSS absolute reduction). Syndromic patients with OSMCP may be more effectively treated with FP (72% IVV vs 79% FP PWSS absolute reduction). Intravelar veloplasty is associated with shorter operative times. Both techniques are associated with low morbidity, improved speech scores, and low reoperative rates.

AB - Background: The safety, efficacy, and direct comparison of various surgical treatments for velopharyngeal insufficiency (VPI) associated with occult submucous cleft palate (OSMCP) are poorly characterized. The aim of this study was to report and analyze the safety and efficacy of Furlow palatoplasty (FP) versus radical intravelar veloplasty (IVV) for treatment of VPI associated with OSMCP. Methods: A retrospective review of one institution's experience treating VPI associated with OSMCP using IVV (group 1) or FP (group 2) during 24 months was performed. Statistical significance was determined by Wilcoxon matched-pair, Independent-Samples Mann-Whitney U, and analysis of variance (SPSS 20.0.0). Results: In group 1 (IVV), 18 patients were identified from August 2010 to 2011 (12 male and 6 female patients; average age, 5.39 years). Seven patients were syndromic and 11 were nonsyndromic. In group 2 (FP), 17 patients were identified from August 2009 to 2011 (8 male and 9 female patients; average age, 8.37 years). Three patients were syndromic and 14 patients were nonsyndromic. There was statistical significance between the average pretreatment Pittsburgh Weighted Speech Score (PWSS) of the 2 groups (group 1 and 2 averages 19.06 and 11.05, respectively, P = 0.002), but there was no statistical significance postoperatively (group 1 and 2 averages 4.50 and 4.69, respectively, P = 0.405). One patient from each group required secondary speech surgery. Average operative time was greater for FP (140 minutes; range, 93-177 minutes) compared to IVV (95 minutes; range, 58-135 minutes), P <0.001. Average hospital stay was 3.9 days for IVV (range, 2-9 days) and 3.2 days for FP (range, 2-6 days), with no significant difference (P = 0.116). There were no postsurgical wound infections, oral-nasal fistulas, postoperative bleeding complications, or mortalities. Conclusions: Nonsyndromic patients with hypernasal speech are treated effectively and safely with either IVVor FP. Intravelar veloplasty trended toward lower speech scores than FP (76% IVV, 58% FP PWSS absolute reduction). Syndromic patients with OSMCP may be more effectively treated with FP (72% IVV vs 79% FP PWSS absolute reduction). Intravelar veloplasty is associated with shorter operative times. Both techniques are associated with low morbidity, improved speech scores, and low reoperative rates.

KW - Cleft palate repair

KW - Congenital

KW - Intravelar veloplasty

KW - Occult submucous cleft palate

KW - Velopharyngeal incompetence

UR - http://www.scopus.com/inward/record.url?scp=84927109902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927109902&partnerID=8YFLogxK

U2 - 10.1097/SAP.0b013e3182956632

DO - 10.1097/SAP.0b013e3182956632

M3 - Article

C2 - 24051463

AN - SCOPUS:84927109902

VL - 74

SP - 182

EP - 186

JO - Annals of Plastic Surgery

JF - Annals of Plastic Surgery

SN - 0148-7043

IS - 2

ER -